Received Oct 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | 1 | 96868 | ID / RA |
Increased speech deficit, R eye dipolopia. ER visit 10/10/25 and 10/11/25 with admission until 10/12/25. Described at that time 3-4 day history of symptoms. Underwent CT head, CT angio head and neck, MRI brain, u/a. Neurology consultation (felt could be psychogenic but noted no new life stressors) vs recrudescence of prior stroke. Improvement by 10/12/25.
N/A
Autonomic dysfunction, autonomic polyneuropathy, bipolar 2 disorder, CVA, CAD (CABG), hypertension, dysphagia, GERD, hemiparesis following CVA with speech and mobility deficit, HIV, hypogonadism, osteoporosis
Aspirin 325 mg, cetirizine 10 mg, dexilant 60 mg, dolutegravir 50 mg, Pifeltro 100 mg, Prezobix 800 mg/150 mg, rosuvastatin 10 mg, tadalafil 5 mg, testosterone 20.25 mg/1.25 grams
Artane, lithium, oxycodone, promethazine, trihexyphenidyl
See above